Hundreds of genetic discoveries from FinnGen study
New results from the FinnGen research consortium include previously unknown genetic risk factors for many debilitating diseases.
Source: labiotech.eu
📰 Genentech News
Page 212 - Genentech News Today
Fast, Ad-Free News Updates
Stay updated with breaking news from Genentech. Real-time updates on events, politics, business and more.
F. Hoffmann-La Roche Ltd: Roche's Tecentriq plus Avastin is the first treatment combination to reduce the risk of cancer returning in people with certain types of early-stage liver cancer in a Phase III trial
Pivotal Phase III IMbrave050 study investigating Tecentriq plus Avastin in people with early-stage hepatocellular carcinoma (HCC) at high risk of recurrence following surgery met primary endpoint of recurrence-free
Source: finanznachrichten.de
Anti-VEGFs considered in cases of severe diabetic retinopathy
KOLOA, Hawaii — When deciding which patients with diabetic retinopathy to treat with anti-VEGFs, ophthalmologists should consider severity of disease, according to a speaker here.
United States Rogera Goldberg Byeamonn Dreisbach Carl Zeiss Meditec Boehringer Ingelheim Ocular Therapeutix
Source: healio.com
Clinical trial-first for liver cancer immunotherapy combination
IMbrave050 is the first Phase III study to show a cancer immunotherapy combo reduced risk of disease recurrence for hepatocellular carcinoma.
Levi Garraway European Medicines Agency Drug Administration Head Of Global Product Development At Roche Chief Medical Officer Global Product Development
Source: europeanpharmaceuticalreview.com
Hinge Bio Expands Senior Management Team to Drive
Barry Selick, Ph.D., successful biopharmaceutical scientist, senior executive and entrepreneur, appointed Chief Executive Officer Carin Rollins, Hinge...
Source: globenewswire.com
BLOG: Case study: Treating central serous chorioretinopathy with MicroPulse laser
Blogs | | A 37-year-old man presented in May 2022 with central serous chorioretinopathy in his left eye. His measured vision was 20/20, but he reported significant visual discomfort.
United States Walnut Creek Christine Klimanskis Bycaesar Luo Bay Area Retina Associates In Walnut Creek Caesar Luo
Source: healio.com
AC Immune Partner Life Molecular Imaging Initiates Phase 3 Study of Tau PET Diagnostic PI-2620 for Alzheimer's Disease
AC Immune Partner Life Molecular Imaging Initiates Phase 3 Study of Tau PET Diagnostic PI-2620 for Alzheimer’s Disease First Alzheimer’s patient imaged with PI-2620 in ADvance, the... | January 18, 2023
Source: marketscreener.com
Pixels, Bots and Human Cruelty | Frontpage Mag
A major book launches, revealing a massive scandal - and grotesque attacks begin.
Source: frontpagemag.com
Switching Patterns Among Neovascular Age-Related Macular Degeneration: Genentech's Vabysmo Rising, Regeneron's Eylea and Genentech's Off-Label Avastin Remain Strong, According to Spherix Global Insights
/PRNewswire/ -- The switch landscape represents an active segment of the market where brands have the opportunity to capture share. Spherixs RealWorld...
Coherus Bioscience Cimerli Genentech Susvimo Scott Upham Genentech Vabysmo Regeneron Eylea Chrystal Ferguson
Source: prnewswire.com
Cancer Dependency Map Consortium accelerates research into tumor vulnerabilities
/PRNewswire/ -- The Broad Institutes Cancer Dependency Map Consortium, an academic-industrial partnership program that was first announced in 2019, is...
Jan Nygaard Jensen Francisca Vazquez Los Angeles William Sellers Broad Institute Depmap Alliance Management
Source: prnewswire.com